Abstract
Cannabis contains more than one hundred and twenty distinct chemical compounds known collectively as cannabinoids. One of those canabinoids is cannabidol, commonly abbreviated and referred to as CBD. While CBD has no psychoactive properties, it may be beneficial for treating specific medical conditions including chronic pain. CBD can be used orally or topically. In its topical form, CBD is typically added to a carrier oil. Topical applications of CBD oils include the management of pain due to arthritis and inflammation. Research continues to mount suggesting the additional benefits of oral administration of CBD to treat epilepsy, multiple sclerosis, chronic pain, and anxiety. Because CBD does not produce known side effects, euphoric or otherwise, it has also garnered attention for its relative safety especially vis-a-vis its sister compounds found in cannabis. CBD also presents tremendous opportunities for market-related growth in the budding international cannabis industry.
Introduction
Cannabidiol (CBD) is one of the many unique chemical compounds found in cannabis or hemp. Unlike its more famous cousin tetrahydrocannabinol (THC), CBD has no psychoactive properties. While CBD may seem to take the fun out of cannabis, the compound has recently been isolated, tested, and marketed on its own as a substance that may be useful for treating various medical conditions. In fact, its lack of psychoactive properties makes it a far more versatile substance than THC and possibly safer to use without any known side effects. Before it can be touted as a miracle drug, though, CBD needs to continue undergoing systematic clinical trials on human subjects. A progressive legal environment and the promise of economic gain from promoting CBD products on the market have together ensured ongoing and fruitful research into its health and therapeutic benefits.
The Legal Environment
Cannabis is legal for medical or recreational purposes in dozens of states and counting, as well as being legal for recreational use across the border in Canada. The increased liberality of cannabis laws has encouraged CBD research and product development. Many states, including a handful of those without legalized recreational cannabis, do tacitly allow for the sale of CBD in spite of its nebulous legal status at the federal level (Rath, n.d.). Currently, only Alabama, Georgia, Indiana, Iowa, Kentucky, Mississippi, Missouri, North Carolina, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Wisconsin and Wyoming have laws that specifically mention CBD...
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now